Antares Pharma understands antagonism towards needles. The company develops needle-free systems for administering injectable drugs. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. The Vision system is used primarily for the delivery of insulin and of human growth hormones; it is available over-the-counter and by prescription in the US and is also sold overseas. In addition to its needle-free systems, the company develops other drug-delivery platforms, including topical gels, orally administered disintegrating tablets, and mini-needle injection systems.